School of International Arbitration (SIA), Queen Mary University of London
WIPO Arbitration and Mediation Center
Parties from the life sciences sector are increasingly using mediation and arbitration to resolve their disputes. Life sciences entities already represent some 15% of users of WIPO Mediation and Arbitration, covering a wide range of disputes faced by pharmaceutical, biosciences, medical devices and chemical industries.
Join us for this year’s SIA-WIPO Symposium, where you will hear from a panel of experts discussing a range of topical issues surrounding the use of mediation and arbitration to resolve life sciences disputes, including options to tailor proceedings and how to draft effective dispute resolution clauses.
June 14, 2022. 3.00 p.m. – 4.30 p.m. CEST
Moderator: Maxi Scherer, Professor, School of International Arbitration, Queen Mary University of London
Rachael Kent, Partner, International Arbitration Practice Group, Wilmer Cutler Pickering Hale and Dorr LLP
Joseph Kirk Jr., Principle Counsel, Global Patent Litigation Department, Sanofi
Julian Lew QC, Head, School of International Arbitration, Queen Mary University of London
Sally Shorthose, Partner, IP & Life Sciences Practice Groups, Bird & Bird LLP
Heike Wollgast, Head, IP Disputes Section, WIPO Arbitration and Mediation Center
Question & Answer